Atrial septal defect post surgical follow up: Difference between revisions
m (Robot: Changing Category:Disease state to Category:Disease) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Atrial septal defect}} | {{Atrial septal defect}} | ||
Revision as of 20:59, 30 August 2012
|
Atrial Septal Defect Microchapters | |
|
Treatment | |
|---|---|
|
Surgery | |
|
| |
|
Special Scenarios | |
|
Case Studies | |
|
Atrial septal defect post surgical follow up On the Web | |
|
American Roentgen Ray Society Images of Atrial septal defect post surgical follow up | |
|
Risk calculators and risk factors for Atrial septal defect post surgical follow up | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3] Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]
Overview
Due to the development of new minimally invasive techniques, percutaneous closure and improvement in surgical closure, most patients with atrial septal defect can start eating and ambulating within the first or second postoperative days. Also, most patients with surgical closure are discharged by the third or fourth postoperative days and patients with percutaneous closure, are generally discharged the next day. Surgical follow-up care is mostly for 1-2 months. Ideally, at least 1 follow-up echocardiogram to confirm complete closure of the atrial septal defect should be obtained. A cardiologist with good experience with heart defects should continue patient care. An yearly follow up to monitor development of complications like arrhythmias should be arranged. Six months of aspirin with or without clopidogrel is recommended for prevention of thrombus formation.
ACC/AHA recommendations for postintervention follow-up in atrial septal defect [1](DONOT EDIT)
| “ |
Postintervention Follow-Up1. Evaluation for postpericardiotomy syndrome with tamponade 2. Annual clinical follow-up in defined patient subgroups 3. Evaluation for possible device migration, erosion, or other complications |
” |
For ACC/AHA Level of evidence and classes click:ACC AHA Guidelines Classification Scheme
References
- ↑ Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.